Dexamethasone serum concentrations after intravenous administration in horses during race training
In: Comparative Exercise PhysiologyDepartment of Veterinary Clinical Sciences College of Veterinary Medicine, Iowa State University, 1800 Christensen Drive, Ames, IA 50011-1134, USA.
Search for other papers by S. McClure in
Current site
Google Scholar
Search for other papers by C. Fenger in
Current site
Google Scholar
Search for other papers by K. Kersh in
Current site
Google Scholar
Search for other papers by B. Brown in
Current site
Google Scholar
Search for other papers by G. Maylin in
Current site
Google Scholar
Search for other papers by W. Duer in
Current site
Google Scholar
Search for other papers by L Dirikolu in
Current site
Google Scholar
Search for other papers by K. Brewer in
Current site
Google Scholar
Search for other papers by J. Machin in
Current site
Google Scholar
Search for other papers by T. Tobin in
Current site
Google Scholar
Dexamethasone (DXM) sodium phosphate is a widely used corticosteroid for inflammatory conditions in horses, regulated in racing jurisdictions in the USA by a 0.005 ng/ml serum/plasma threshold. This study seeks to describe serum concentrations of DXM at 48 and 72 h after intravenous administration of 20 mg DXM sodium phosphate over 1 to 5 days, and to identify a possible source of DXM overages. 74 horses (39 Thoroughbreds, 13 Standardbreds, 22 Quarter Horses) in active race training received 20 mg DXM sodium phosphate. Serum was collected before injection, at 48 and 72 h post last injection, and analysed by LC/MS-MS (limit of quantification (LOQ) = 2.5 pg/ml). No differences were identified by ANOVA (P≤0.05) for racing breeds, age, gender or the number of days of DXM sodium phosphate administration, so data were pooled for each time point. The DXM serum concentration at 48 h (mean ± standard deviation, range) was 2.18±1.56 pg/ml (<2.5 to 40 pg/ml). Summary statistics could not be derived for 72 h DXM serum concentration data owing to censored data, but ranged from <2.5 to 95.8 pg/ml. There was one extreme outlier (Tukey) at 48 h, and two extreme outliers at 72 h. A separate study was conducted using sedentary experimental horses to determine the likelihood that positive DXM samples could result from environmental transfer. Urine was collected from a mare 2 to 3 h post administration of 20 mg DXM. Hay with 100 ml of the DXM (17 ng/ml) containing urine was offered to each of six experimental horses and blood was collected at 0, 4, 8, 12, 16, 20 and 24 h. All six horses had plasma DXM concentration above the limit of detection and five of six had plasma DXM concentrations above the LOQ for at least one sample time.
-
Anonymous, 2016. Elimination guidelines 2016. Canadian Pari-Mutuel Agency, Ottawa, ON, Canada.
-
Anonymous, 2018. FEI list of detection times. Available at: https://tinyurl.com/y5ncfqjc
-
Association of Racing Commissioners International (ARCI), 2019. Dexamethasone violations. Violations database, ARCI, Lexington, KY, USA.
-
Barker, S.A., 2008. Drug contamination of the equine racetrack environment: a preliminary examination. Journal of Veterinary Pharmacology and Therapeutics 31: 466-471.
'Drug contamination of the equine racetrack environment: a preliminary examination ' () 31 Journal of Veterinary Pharmacology and Therapeutics : 466 -471.
-
Chen, C.L., Zhu, D., Gillis, K.D. and Meleka-Boules, M., 1996. Use of enzyme-linked immunosorbent assay to determine serum and urine dexamethasone concentrations in Thoroughbreds after intravenous administration of the steroid. American Journal of Veterinary Research 57: 182-186.
'Use of enzyme-linked immunosorbent assay to determine serum and urine dexamethasone concentrations in Thoroughbreds after intravenous administration of the steroid ' () 57 American Journal of Veterinary Research : 182 -186.
-
Christley, R.M., Hodgson, D.R., Rose, R.J., Wood, J.L., Reids, S.W., Whitear, K.G. and Hodgson, J.L., 2001. A case-control study of respiratory disease in Thoroughbred racehorses in Sydney, Australia. Equine Veterinary Journal 33: 256-264.
'A case-control study of respiratory disease in Thoroughbred racehorses in Sydney, Australia ' () 33 Equine Veterinary Journal : 256 -264.
-
Couëtil, L.L., Cardwell, J.M., Gerber, V., Lavoie, J.P., Léguillette, R. and Richard, E.A., 2016. Inflammatory airway disease of horses – revised consensus statement. Journal of Veterinary Internal Medicine 30: 503-515.
'Inflammatory airway disease of horses – revised consensus statement ' () 30 Journal of Veterinary Internal Medicine : 503 -515.
-
Fitch, K., 2016. Glucocorticoids at the Olympic Games: state-of-the-art review. British Journal of Sports Medicine 50: 1267.
'Glucocorticoids at the Olympic Games: state-of-the-art review ' () 50 British Journal of Sports Medicine : 1267.
-
Grady, J.A., Davis, E.G. KuKanich, B. and Sherck, A.B., 2010. Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses. American Journal of Veterinary Research 71: 831-839.
'Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses ' () 71 American Journal of Veterinary Research : 831 -839.
-
Haspel, A.D., Giguere, S., Hart, K.A., Berghaus, L.J. and Davis, J.L., 2018. Bioavailability and tolerability of nebulised dexamethasone sodium phosphate in adult horses. Equine Veterinary Journal 50: 85-90.
'Bioavailability and tolerability of nebulised dexamethasone sodium phosphate in adult horses ' () 50 Equine Veterinary Journal : 85 -90.
-
Helsel, D.R., 2012. Robust imputation and NADA (nondetects and data analysis for R software). In: Helsel, D.R. (ed.) Statistics for censored environmental data using Minitab® and R, 2nd edition. Wiley and Sons, Hoboken, NJ, USA, pp. 79-98 and 297-302.
'Robust imputation and NADA (nondetects and data analysis for R software) ', () 79 -302.
-
Khazaeinia, T., Ramsey, A.A. and Tam, Y.K., 2000. The effects of exercise on the pharmacokinetics of drugs. Journal of Pharmacy and Pharmaceutical Sciences 3: 292-302.
'The effects of exercise on the pharmacokinetics of drugs ' () 3 Journal of Pharmacy and Pharmaceutical Sciences : 292 -302.
-
Li, L., Li, X., Xu, L., Sheng, Y., Huang, J. and Zheng, Q., 2013. Systematic evaluation of dose accumulation studies in clinical pharmacokinetics. Current Drug Metabolism 14: 605-615.
'Systematic evaluation of dose accumulation studies in clinical pharmacokinetics ' () 14 Current Drug Metabolism : 605 -615.
-
Machin, J., Duer, W.C., Maylin, G.A., Fenger, C.K., Wilson, D., Ivey, M., Berthold, B., Allison, S. and Tobin, T., 2019. Variability in plasma concentrations of methylprednisolone six days after intra-synovial injection of methylprednisolone acetate as depo-medrol in racing horses: a field study. Equine Veterinary Journal 51: 343-348.
'Variability in plasma concentrations of methylprednisolone six days after intra-synovial injection of methylprednisolone acetate as depo-medrol in racing horses: a field study ' () 51 Equine Veterinary Journal : 343 -348.
-
McKane, S.A. and Slocombe, R.F., 2010. Experimental mild pulmonary inflammation promotes the development of exercise-induced pulmonary haemorrhage. Equine Veterinary Journal 42, Suppl. 38: 235-239.
'Experimental mild pulmonary inflammation promotes the development of exercise-induced pulmonary haemorrhage ' () 42 Equine Veterinary Journal : 235 -239.
-
Owen, D.B., 1968. A survey of properties and applications of the non-centrally t-distribution. Technometrics 10: 445-478.
'A survey of properties and applications of the non-centrally t-distribution ' () 10 Technometrics : 445 -478.
-
Popot, M.A., Garcia, P. and Bonnaire, Y., 2011. Doping control in horses: housing conditions and oral recycling of flunixin by ingestion of contaminated straw. Journal of Veterinary Pharmacology and Therapeutics 34: 612-614.
'Doping control in horses: housing conditions and oral recycling of flunixin by ingestion of contaminated straw ' () 34 Journal of Veterinary Pharmacology and Therapeutics : 612 -614.
-
Rumpler, M.J., Colahan, P. and Sams, R.A., 2014. The pharmacokinetics of glycopyrrolate in Standardbred horses. Journal of Veterinary Pharmacology and Therapeutics 37: 260-268.
'The pharmacokinetics of glycopyrrolate in Standardbred horses ' () 37 Journal of Veterinary Pharmacology and Therapeutics : 260 -268.
-
Russell, C.S. and Maynard, S., 2000. Environmental contamination with isoxsuprine. In: Williams, R.B., Houghton, E. and Wade, J.F. (eds.) Proceedings of the 13th International Conference of Racing Analysts and Veterinarians, Cambridge. R&W Publications, Newmarket, UK, p. 383.
Environmental contamination with isoxsuprine 383
-
Samtani M.N. and Jusko, W.J., 2005. Stability of dexamethasone sodium phosphate in rat plasma. International Journal of Pharmaceutics 301: 262-266.
'Stability of dexamethasone sodium phosphate in rat plasma ' () 301 International Journal of Pharmaceutics : 262 -266.
-
Savage, R., 1961. Probability inequalities of the Tchebycheff (Chebyshev) type. Journal of Research of the National Bureau of Standards, Section B: 65B: 211-222.
'Probability inequalities of the Tchebycheff (Chebyshev) type ' () 65B Journal of Research of the National Bureau of Standards, Section B : 211 -222.
-
Soma, L.R., Uboh, C.E., Liu, Y., Li, X., Robinson, M.A., Boston, R.C. and Colahan, P.T., 2012. Pharmacokinetics of dexamethasone following intra-articular, intravenous, intramuscular, and oral administration in horses and its effects on endogenous hydrocortisone. Journal of Veterinary Pharmacology and Therapeutics 36: 181-191.
'Pharmacokinetics of dexamethasone following intra-articular, intravenous, intramuscular, and oral administration in horses and its effects on endogenous hydrocortisone ' () 36 Journal of Veterinary Pharmacology and Therapeutics : 181 -191.
-
Soma, L.R., Uboh, C.E., Luo, Y., Guan, F., Moate, P.J. and Boston, R.C., 2005. Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse. Journal of Veterinary Pharmacology and Therapeutics 28: 71-80.
'Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse ' () 28 Journal of Veterinary Pharmacology and Therapeutics : 71 -80.
-
Symonds, N.E., Dart, A.J., Keledjian, J., Liu Lau, M., Ennis, L.C., McIver, V.C., Tsang, A.S., Biasutti, S.A. and Jeffcott, L.B., 2019. Pilot study to quantify the time to clear dexamethasone from plasma and urine of adult horses following a single nebulization. Australian Veterinary Journal 97: 144-148.
'Pilot study to quantify the time to clear dexamethasone from plasma and urine of adult horses following a single nebulization ' () 97 Australian Veterinary Journal : 144 -148.
-
Tobin, T., 1981. Drugs and the performance horse. Charles C. Thomas, Springfield, IL, USA, pp. 480.
'Drugs and the performance horse ', () 480.
-
Vanhaecke, L., Antignac, J.P., Courtheyn, D., Le Bizec, B. and De Brabandera, H., 2011. Elimination kinetics of dexamethasone in bovine urine, hair and feces following single administration of dexamethasone acetate and phosphate esters. Steroids 76: 111-117.
'Elimination kinetics of dexamethasone in bovine urine, hair and feces following single administration of dexamethasone acetate and phosphate esters ' () 76 Steroids : 111 -117.
-
Wennerlund, I., Invast-Larrson, C., Kallings, P., Fredrickson, E. and Bondesson, U., 2000. Pharmacokinetics and urinary excretion of naproxen after repeated oral administration in the horse. In: Williams, R.B., Houghton, E. and Wade, J.F. (eds.) Proceedings of the 13th International Conference of Racing Analysts and Veterinarians, Cambridge. R&W Publications, Newmarket, UK, pp. 377-380.
Pharmacokinetics and urinary excretion of naproxen after repeated oral administration in the horse 377 380
-
Wood, J.L., Newton, J.R., Chanter, N. and Mumford, J.A., 2005. Association between respiratory disease and bacterial and viral infections in British racehorses. Journal of Clinical Microbiology 43: 120-126.
'Association between respiratory disease and bacterial and viral infections in British racehorses ' () 43 Journal of Clinical Microbiology : 120 -126.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 424 | 204 | 28 |
| PDF Views & Downloads | 302 | 140 | 7 |
Dexamethasone serum concentrations after intravenous administration in horses during race training
In: Comparative Exercise PhysiologyDepartment of Veterinary Clinical Sciences College of Veterinary Medicine, Iowa State University, 1800 Christensen Drive, Ames, IA 50011-1134, USA.
Search for other papers by S. McClure in
Current site
Google Scholar
PubMed
Search for other papers by C. Fenger in
Current site
Google Scholar
PubMed
Search for other papers by K. Kersh in
Current site
Google Scholar
PubMed
Search for other papers by B. Brown in
Current site
Google Scholar
PubMed
Search for other papers by G. Maylin in
Current site
Google Scholar
PubMed
Search for other papers by W. Duer in
Current site
Google Scholar
PubMed
Search for other papers by L Dirikolu in
Current site
Google Scholar
PubMed
Search for other papers by K. Brewer in
Current site
Google Scholar
PubMed
Search for other papers by J. Machin in
Current site
Google Scholar
PubMed
Search for other papers by T. Tobin in
Current site
Google Scholar
PubMed
Dexamethasone (DXM) sodium phosphate is a widely used corticosteroid for inflammatory conditions in horses, regulated in racing jurisdictions in the USA by a 0.005 ng/ml serum/plasma threshold. This study seeks to describe serum concentrations of DXM at 48 and 72 h after intravenous administration of 20 mg DXM sodium phosphate over 1 to 5 days, and to identify a possible source of DXM overages. 74 horses (39 Thoroughbreds, 13 Standardbreds, 22 Quarter Horses) in active race training received 20 mg DXM sodium phosphate. Serum was collected before injection, at 48 and 72 h post last injection, and analysed by LC/MS-MS (limit of quantification (LOQ) = 2.5 pg/ml). No differences were identified by ANOVA (P≤0.05) for racing breeds, age, gender or the number of days of DXM sodium phosphate administration, so data were pooled for each time point. The DXM serum concentration at 48 h (mean ± standard deviation, range) was 2.18±1.56 pg/ml (<2.5 to 40 pg/ml). Summary statistics could not be derived for 72 h DXM serum concentration data owing to censored data, but ranged from <2.5 to 95.8 pg/ml. There was one extreme outlier (Tukey) at 48 h, and two extreme outliers at 72 h. A separate study was conducted using sedentary experimental horses to determine the likelihood that positive DXM samples could result from environmental transfer. Urine was collected from a mare 2 to 3 h post administration of 20 mg DXM. Hay with 100 ml of the DXM (17 ng/ml) containing urine was offered to each of six experimental horses and blood was collected at 0, 4, 8, 12, 16, 20 and 24 h. All six horses had plasma DXM concentration above the limit of detection and five of six had plasma DXM concentrations above the LOQ for at least one sample time.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 424 | 204 | 28 |
| PDF Views & Downloads | 302 | 140 | 7 |
